State and local governments are increasingly staking out more aggressive roles in regulating marketing practices by pharmaceutical manufacturers, particularly with respect to the use of prescriber-identifiable data (PID). A federal court recently upheld a Vermont law restricting the sale and use of PID by pharmacies, pharmaceutical manufacturers and others. Massachusetts also recently implemented far-reaching regulations that not only regulate the use of PID, but impose other restrictions on detailing by manufacturers of pharmaceuticals as well as medical devices. Many other states are considering additional restrictions.
This teleconference will explore the recent ruling on the Vermont law and the status of other legal challenges to laws restricting the use of PID, as well as the broader marketing restrictions enacted recently by Massachusetts and those enacted or under consideration in other states. We also will highlight key compliance issues raised by these regulations.
Scott Stein is a partner in Sidley’s Healthcare Practice who has worked extensively with pharmaceutical and medical device manufacturers on a variety of issues, including issues relating to marketing and the use of prescriber-identifiable data and issues relating to fraud and abuse.
Meenakshi Datta is an associate in Sidley’s Healthcare Practice. She has substantial experience counseling in various areas of healthcare regulatory law including sales and marketing, fraud and abuse and healthcare compliance programs.
Thursday, May 14, 2009
2:00 – 3:30 p.m. Eastern Time
RSVP by Tuesday, May 12 to firstname.lastname@example.org or 202.736.8565.
You will receive a dial-in number upon registering.
Please note: This non-transitional program is approved for NY and IL CLE credits for experienced attorneys only. It is not acceptable for newly admitted attorneys.